HLB Therapeutics Co (XKRX:115450) Interest Expense : ₩-1,964 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. HLB Therapeutics Co's interest expense for the three months ended in Dec. 2024 was ₩ -464 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1,964 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. HLB Therapeutics Co's Operating Income for the three months ended in Dec. 2024 was ₩ 16 Mil. HLB Therapeutics Co's Interest Expense for the three months ended in Dec. 2024 was ₩ -464 Mil. HLB Therapeutics Co's Interest Coverage for the quarter that ended in Dec. 2024 was 0.03. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HLB Therapeutics Co Interest Expense Historical Data

The historical data trend for HLB Therapeutics Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Interest Expense Chart

HLB Therapeutics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-4,254.44

-1,160.43

-5,146.35

-1,111.65

-1,964.30

HLB Therapeutics Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-271.32	-365.11	-665.35	-470.20	-463.64

HLB Therapeutics Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,964 Mil.

HLB Therapeutics Co (XKRX:115450) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HLB Therapeutics Co's Interest Expense for the three months ended in Dec. 2024 was ₩-464 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩16 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩5,371 Mil.

HLB Therapeutics Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	15.858	/	-463.638
	=	0.03

The higher the ratio, the stronger the company's financial strength is.

HLB Therapeutics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811

Website

https://www.hlbtherapeutics.co.kr

HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co Headlines

No Headlines